Table 3.
T2DM group n = 297 | NGT group n = 169 | Meta‐analysis | Heterogeneity tests | ||||
---|---|---|---|---|---|---|---|
B ± SE† | P‐value | B ± SE† | P‐value | B ± SE‡ | P‐value | I 2 (%) | |
LDL‐c (mmol/L) | −0.120 ± 0.057 | 0.037 | 0.030 ± 0.063 | 0.632 | −0.047 ± 0.075 | 0.527 | 67.92 |
HDL‐c (mmol/L) | −0.041 ± 0.017 | 0.015 | −0.009 ± 0.027 | 0.725 | −0.032 ± 0.014 | 0.027 | 0.59 |
TC (mmol/L) | −0.256 ± 0.076 | 0.001 | 0.088 ± 0.077 | 0.252 | −0.089 ± 0.176 | 0.615 | 90.61 |
Triglycerides (mmol/L)§ | −0.068 ± 0.039 | 0.082 | −0.083 ± 0.041 | 0.046 | −0.075 ± 0.028 | 0.008 | 0 |
SBP (mmHg) | −0.220 ± 1.312 | 0.867 | 2.210 ± 1.139 | 0.054 | 1.166 ± 0.086 | 0.175 | 48.88 |
DBP (mmHg) | −0.421 ± 0.723 | 0.561 | 1.454 ± 0.693 | 0.037 | 0.528 ± 0.937 | 0.573 | 71.47 |
GGT (U/L)§ | −0.056 ± 0.045 | 0.210 | −0.013 ± 0.050 | 0.794 | −0.037 ± 0.033 | 0.272 | 0 |
ALT (U/L)§ | −0.022 ± 0.033 | 0.508 | −0.008 ± 0.041 | 0.851 | −0.016 ± 0.026 | 0.521 | 0 |
AST (U/L)§ | −0.050 ± 0.025 | 0.046 | 0.007 ± 0.025 | 0.786 | −0.022 ± 0.018 | 0.224 | 61.53 |
†The B ± standard error (SE) value shown indicates the association of 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid with anthropometric parameters and biochemical indexes separately in the two groups by linear regression after adjustment for age, sex and body mass index. ‡The B ± SE value shown represents the association of ‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid with anthropometric parameters and biochemical indexes by combining the two groups with a fixed‐effects model for high‐density lipoprotein cholesterol (HDL‐c), triglyceride (TG), γ‐glutamyltransferase (GGT) and alanine aminotransferase (ALT), and a random‐effects model for low‐density lipoprotein cholesterol (LDL‐c), total cholesterol (TC), systolic blood pressure (SBP), diastolic blood pressure (DBP) and aspartate transaminase (AST). I 2 was used to assess heterogeneity. §Log transformed before analysis.